Larson Financial Group’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Other funds holding DYN
Larson Financial Group's DYN Position: Q3 2026 in Review
Larson Financial Group increased its Dyne Therapeutics (DYN) stake by 9.9% in Q3 2026, buying an estimated $1.82K and bringing the position to 875 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2327.
Larson Financial Group first reported a position in DYN in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.7K in Q2 2026. 270 funds tracked by Wall St. Rank hold DYN as of Q3 2026.
- Larson Financial Group held 875 shares of Dyne Therapeutics worth $14.1K as of Q3 2026.
- Larson Financial Group bought 79 Dyne Therapeutics shares in Q3 2026, an estimated $1.82K.
- Dyne Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2327 holding.
- Larson Financial Group first reported a position in Dyne Therapeutics in Q1 2025 and has held it in 6 quarters since.
- Larson Financial Group's Dyne Therapeutics position peaked at $17.7K in Q2 2026.
- 270 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.